You are here: Industry Insights > DCGI

News List

DCGI approves Nintedanib for the treatment of systemic sclerosis-associated interstitial lung diseas expresspharma
May 21, 2020
Approval is based on the SENSCIS study which showed Nintedanib slows the loss of pulmonary function in people living with systemic sclerosis-associated ILD (SSc-ILD).
DCGI approves Glenmark’s clinical trials of Favipiravir Antiviral tablets for COVID-19 patients expresspharma
April 30, 2020
The product is a generic version of Avigan of Fujifilm Toyama Chemical, Japan, a subsidiary of Fujifilm Corporation.
Industry lauds move to allow import of drugs with 60 per cent residual shelf life expresspharma
April 26, 2020
Revised guidelines will ease the movement of goods and enable timely access to medicines, benefitting both pharma companies and patients.
DCGI instructs SDCs to monitor supply and availability of paracetamol tablets, APIs expresspharma
April 24, 2020
Manufacturers of paracetamol tablets need to supply the minimum quantity but not less than their average supply of the past three months (January, February and March) in the domestic market.
MDR TB drug by Otsuka made its way to India biospectrumasia
August 28, 2017
The Drug Controller General of India (DCGI), India’s apex drug regulator, has granted Mylan’s subsidiary approval for the drug.

Previous page 1 2 3 4 5 6 7 8 9 10 Next page